Elderly in homes to get shots, keep pneumonia away

CHENNAI: Come April, nurses and doctors at primary health centres will fan out to administer their annual vaccination shots. Only this time, the beneficiaries won’t be children but the elderly.

In an effort to tackle the high prevalence of pneumonia among the elderly, the state government will soon roll out a programme to vaccinate destitute elderly in old age homes aided by the state and central governments.

The social welfare department has identified 4,133 elderly people who will be vaccinated in the drive. The state planning commission recently gave the go-ahead for the project, which is estimated to cost Rs1.65 crore.

Pneumonia affects people who have low immunity like children, patients in intensive-care units, those having chronic conditions like diabetes, people suffering from cancer and the elderly.

“While immunisation coverage is high for children, few realise or recognise the need to vaccinate the elderly,” said geriatric care specialist Dr V S Natarajan. The immune system, he said, starts to decline around 50 years of age. “After this, people will need booster shots. One shot will give them lifelong immunity,” said the doctor.

Pneumonia, Dr Natarajan said, is a common precipitating factor for various ailments like stroke and heart attack. “People cooped up in a place are more susceptible as this infection is air-borne, which is why it’s important to vaccinate those staying in old age homes,” said Dr Natarajan, who was consulted for the programme.

People working with the elderly said although the prevalence of pneumonia is high in old age homes, caregivers are reluctant to vaccinate them owing to the cost. Each vaccine shot costs Rs 3,800. “We’ve repeatedly appealed to the state government to roll out a programme for this group as many of them can’t afford the cost of the vaccine,” said Sivakumar V, Tamil Nadu head of NGO HelpAge India.

The social welfare department has identified more than 50 old age homes, three multi-care centres for older widows, four day care centres and two respite care homes across the state. “We’ve identified the nearest government healthcare facility close to these homes. A staff nurse and doctor will be assigned to visit these homes,” said the official.

  • Related Posts

    Chandigarh News: Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered – Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered

    Chandigarh:  A case has been registered against a pharmaceutical company for trying to mislead PGI by creating a fake letter from CDSCO (Central Drugs Standard Control Organisation) Baddi to prove…

    Kushinagar News: Truck Was Traveling From Ghaziabad To Agartala, Mystery Revealed When It Overturned

    Case of codeine syrup being hidden among sugar sacks in a truck. After receiving the documents, the pharmaceutical department sent them to Ghaziabad and Agartala and started investigation. Kushinagar/Rahsu Bazaar.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Regular Supplier Of Stents Ignored By Doctors Due To Low Commission; Company Supplying Despite Crores Of Dues

    Regular Supplier Of Stents Ignored By Doctors Due To Low Commission; Company Supplying Despite Crores Of Dues

    ACB Gujarat Nabs Female Drug Inspector In A Bribe Case

    ACB Gujarat Nabs Female Drug Inspector In A Bribe Case

    Netherlands: Health Secy Visits Bilthoven Biologicals, Discusses Collaboration On Production Of Oral Polio Vaccine

    Netherlands: Health Secy Visits Bilthoven Biologicals, Discusses Collaboration On Production Of Oral Polio Vaccine

    India Lifts Safeguard Measures On Isopropyl Alcohol Imports

    India Lifts Safeguard Measures On Isopropyl Alcohol Imports

    Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

    Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

    Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

    Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines